Logo image of ACB

AURORA CANNABIS INC (ACB) Stock Overview

USA - NASDAQ:ACB - CA05156X8504 - Common Stock

6.17 USD
+0.36 (+6.2%)
Last: 10/7/2025, 8:08:17 PM
6.1 USD
-0.07 (-1.13%)
After Hours: 10/7/2025, 8:08:17 PM

ACB Key Statistics, Chart & Performance

Key Statistics
52 Week High6.91
52 Week Low3.42
Market Cap347.06M
Shares56.25M
Float56.22M
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-0.25
PEN/A
Fwd PE18.34
Earnings (Next)11-04 2025-11-04/bmo
IPO09-26 2007-09-26
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals


ACB short term performance overview.The bars show the price performance of ACB in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 10 20 30 40

ACB long term performance overview.The bars show the price performance of ACB in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 20 -20 -40

The current stock price of ACB is 6.17 USD. In the past month the price increased by 22.18%. In the past year, price increased by 12.8%.

AURORA CANNABIS INC / ACB Daily stock chart

ACB Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
LLY ELI LILLY & CO 52.24 798.46B
JNJ JOHNSON & JOHNSON 18.89 454.91B
AZN ASTRAZENECA PLC-SPONS ADR 19.34 266.24B
NVO NOVO-NORDISK A/S-SPONS ADR 15.09 262.25B
NVS NOVARTIS AG-SPONSORED ADR 14.86 254.66B
MRK MERCK & CO. INC. 11.38 218.83B
PFE PFIZER INC 7.75 149.36B
SNY SANOFI-ADR 11.08 119.89B
BMY BRISTOL-MYERS SQUIBB CO 6.64 90.90B
GSK GSK PLC-SPON ADR 9.65 87.55B
ZTS ZOETIS INC 22.95 63.27B
TAK TAKEDA PHARMACEUTIC-SP ADR 49.86 45.67B

About ACB

Company Profile

ACB logo image Aurora Cannabis, Inc. engages in the production, distribution, and sale of cannabis and cannabis-derivative products. The company is headquartered in Leduc, Alberta and currently employs 1,101 full-time employees. The company went IPO on 2007-09-26. The Company’s principal business lines are focused on the production, distribution and sale of cannabis and cannabis-derivative products in Canada and internationally. The Company’s segments include Cannabis and Plant Propagation. The firm's adult-use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, IndiMed and CraftPlant. The firm also holds a 50.1% controlling interest in Bevo Farms Ltd., a supplier of propagated vegetables and ornamental plants in North America. Its subsidiaries include Aurora Cannabis Enterprises Inc., Aurora Deutschland GmbH, Whistler Medical Marijuana Corporation, and Indica Industries Pty Ltd., among others.

Company Info

AURORA CANNABIS INC

2207 90B Street Sw

Leduc ALBERTA T5J 1Y6 CA

CEO: Terry Booth

Employees: 1073

ACB Company Website

ACB Investor Relations

Phone: 16043625207

AURORA CANNABIS INC / ACB FAQ

What is the stock price of AURORA CANNABIS INC today?

The current stock price of ACB is 6.17 USD. The price increased by 6.2% in the last trading session.


What is the ticker symbol for AURORA CANNABIS INC stock?

The exchange symbol of AURORA CANNABIS INC is ACB and it is listed on the Nasdaq exchange.


On which exchange is ACB stock listed?

ACB stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for AURORA CANNABIS INC stock?

9 analysts have analysed ACB and the average price target is 5.8 USD. This implies a price decrease of -5.95% is expected in the next year compared to the current price of 6.17. Check the AURORA CANNABIS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is AURORA CANNABIS INC worth?

AURORA CANNABIS INC (ACB) has a market capitalization of 347.06M USD. This makes ACB a Small Cap stock.


How many employees does AURORA CANNABIS INC have?

AURORA CANNABIS INC (ACB) currently has 1073 employees.


What are the support and resistance levels for AURORA CANNABIS INC (ACB) stock?

AURORA CANNABIS INC (ACB) has a support level at 6.16 and a resistance level at 6.18. Check the full technical report for a detailed analysis of ACB support and resistance levels.


Is AURORA CANNABIS INC (ACB) expected to grow?

The Revenue of AURORA CANNABIS INC (ACB) is expected to grow by 8.72% in the next year. Check the estimates tab for more information on the ACB EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy AURORA CANNABIS INC (ACB) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does AURORA CANNABIS INC (ACB) stock pay dividends?

ACB does not pay a dividend.


When does AURORA CANNABIS INC (ACB) report earnings?

AURORA CANNABIS INC (ACB) will report earnings on 2025-11-04, before the market open.


What is the Price/Earnings (PE) ratio of AURORA CANNABIS INC (ACB)?

AURORA CANNABIS INC (ACB) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.25).


What is the Short Interest ratio of AURORA CANNABIS INC (ACB) stock?

The outstanding short interest for AURORA CANNABIS INC (ACB) is 11.68% of its float. Check the ownership tab for more information on the ACB short interest.


ACB Technical Analysis

ChartMill assigns a technical rating of 8 / 10 to ACB. When comparing the yearly performance of all stocks, ACB is one of the better performing stocks in the market, outperforming 83.88% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

ACB Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to ACB. Both the profitability and financial health of ACB have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ACB Financial Highlights

Over the last trailing twelve months ACB reported a non-GAAP Earnings per Share(EPS) of -0.25. The EPS increased by 44.79% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -2.32%
ROE -3.53%
Debt/Equity 0.07
Chartmill High Growth Momentum
EPS Q2Q%-307.69%
Sales Q2Q%17.48%
EPS 1Y (TTM)44.79%
Revenue 1Y (TTM)28.42%

ACB Forecast & Estimates

9 analysts have analysed ACB and the average price target is 5.8 USD. This implies a price decrease of -5.95% is expected in the next year compared to the current price of 6.17.

For the next year, analysts expect an EPS growth of -288.53% and a revenue growth 8.72% for ACB


Analysts
Analysts73.33
Price Target5.8 (-6%)
EPS Next Y-288.53%
Revenue Next Year8.72%

ACB Ownership

Ownership
Inst Owners15.09%
Ins Owners0.03%
Short Float %11.68%
Short Ratio4.03